Base
Notice2019-035272019-02-28

Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium

Justice Department, Antitrust Division

Document Excerpt

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Justice Antitrust Division Notice is hereby given that, on January 28, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (“the Act”), Medical CBRN Defense Consortium (“MCDC”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Altimmune, Inc., Gaithersburg, MD; Attogene Corp, Austin, TX; Autonomous Therapeutics, Inc., Brooklyn, NY; Government ( printed page 6822) Scientific Source (GSS), Reston, VA; Lauren Sciences, New York, NY; Locus Biosciences, Morrisville, NC; Maxim Biomedical, Inc., Rockville, MD; MedsForAll, Inc., Seattle, WA; Pirouette Medical, Boston, MA; and University of Washington, Seattle, WA, have been added as parties to this venture. Also, AEQUOR, Inc., Oceanside, CA; Albany Molecular Research Inc. (AMRI), Albany, NY; Binergy Scientific, Inc., Atlanta, GA; New Mexico Institute of Mining and Technology, Socorro, NM; Polo Custom Products, Topeka, KS; and SENTEL Corporation, Alexandria, VA, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project rem

Read full document on FederalRegister.gov →

Full Document

Citation: 84 FR 6821

Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium — Federal Register 2019-03527 | Open Gov by Base